The Epilepsy Foundation - 3 Grants

The Epilepsy Foundation supports a series of grants and fellowships to advance the understanding of epilepsy that will lead to better treatment, more effective prevention, and ultimately to a cure. Funding is available to researchers at all professional levels including students, junior investigators and established investigators. Deadlines for submission are Feb. 16 and Mar. 20

The UNC Office of Corporate and Foundation Relations has identified the following private funding opportunities:

The Epilepsy Foundation - 3 Grants
Epilepsy Foundation - New Therapy Commercialization Grants Program – no amount stated - LOI deadline: February 16, 2015
Epilepsy Innovation Seal of Excellence Award - $25K - LOI deadline: February 16, 2015
Targeted Research Initiative for Morbidity and Mortality - $50K - March 20, 2015

The Epilepsy Foundation 

http://www.epilepsy.com/accelerating-new-therapies/our-research-program/grant-and-fellowship-opportunities

http://www.epilepsy.com/accelerating-new-therapies/our-research-program/research/new-therapy-commercialization-grant-program/how-to-apply

http://www.epilepsy.com/node/2001471 

The Epilepsy Foundation supports a series of grants and fellowships to advance the understanding of epilepsy that will lead to better treatment, more effective prevention, and ultimately to a cure. Funding is available to researchers at all professional levels including students, junior investigators and established investigators. 

The following opportunities are now available for Spring 2015

 Epilepsy Foundation - New Therapy Commercialization Grants Program

  • LOI deadline: February 16, 2015, 11:59 PM ET
  • No funding amount stated

The Epilepsy Foundation - New Therapy Commercialization Grants Program supports the development of more effective therapies by serving as a catalyst for moving innovative therapies from the laboratory to the patient. Investigators must hold a relevant advanced degree (M.D., and/or Ph.D.), and have completed all research training. This call for proposals is open to investigators at corporations as well as the academic/university arena.

Epilepsy Foundation - New Therapy Commercialization Grants Program information and application instructions.

Epilepsy Foundation - New Therapy Commercialization Grants Program focuses on:

  • Research with potential to discover new therapies and a cure for seizure disorders.
  • Meaningful grants to senior level scientific and clinical investigators on the brink of new discoveries, working at the nation's leading academic and research institutions, and in industry.
  • Innovative cutting edge projects that could lead to breakthrough discoveries.
  • Research programs that might not otherwise be funded through traditional sources.
  • Projects that encourage collaboration among scientists and industry.  Every day, millions of people lose seconds, minutes or hours of their lives to seizures. These precious moments can never be regained. That's why the Epilepsy Foundation - New Therapy Commercialization Grants Program funds research with the potential to discover new treatment options and ultimately a cure. The following are the most recent Epilepsy Foundation - New Therapy Commercialization Grants Program awards: 

Epilepsy Innovation Seal of Excellence award

  • LOI deadline: February 16, 2015, 11:59 PM ET

The Epilepsy Innovation Seal of Excellence award is similar to the Epilepsy Foundation - New Therapy Commercialization Grants (NTCG) Program above, designed to accelerate the advancement of research from the laboratory to the patient. SEALs are provided to academic and commercial groups worldwide. The program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. Drug development may be stimulated at the early phases leading to an IND.

The Epilepsy Innovation Seal of Excellence award is not primarily a grant program. The program provides a competitive, in-depth review by the Scientific and Business Advisory Boards, an actual SEAL that may be used by the awardee to generate interest in the project, and a one-time $25,000 grant for the research. The SEAL is award for one year, renewable upon application, for up to a total of four years; the funding for this award is only provided for the first year. The applicants will typically have a research budget of between 1 and $5M for the overall project--amounts that currently exceed the resources of the Epilepsy Foundation. The Epilepsy Foundation will assist the awardees in finding funds for the selected projects.

Epilepsy Innovation Seal of Excellence award information and application instructions.

Targeted Research Initiative for Morbidity and Mortality

The Targeted Research Initiative for Morbidity and Mortality supports research that generates initial data leading to more extensive projects that will generate knowledge that will ultimately improve the lives of persons with epilepsy. This initiative recognizes the need for research and new insights into these scientific areas. The broad focus of the morbidity portion of this program includes: identification of somatic comorbidities in epilepsy that occur more than expected among controls, including but not limited to diabetes, gastrointestinal bleeding, chronic lung disease, congenital cardiac abnormalities, heart failure, and pneumonia; and associations between somatic comorbidities in epilepsy and epilepsy outcomes, including quality of life in epilepsy, seizure remission, stigma and other outcomes. The mortality portion of the program is focused upon potentially preventable causes of death in epilepsy, such as accidents, suicide and SUDEP. Applicants are encouraged to examine risk factors for these causes of death in epilepsy; as well as interventions to decrease the presence of risk factors for these causes of death where risk factors have been identified.

The UNC Office of Corporate and Foundation Relations is available to provide assistance in pursuing privately funded opportunities. Email cfr@unc.edu or phone 919.962.3423.

Filed under: